One Year Study of Rifaximin Delayed Release (DR) in Crohn's Disease
Public ClinicalTrials.gov record NCT02240108. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Multiregional, One Year Study to Assess the Efficacy and Safety of Twice Daily Oral Rifaximin Delayed Release Tablets for Induction of Clinical Remission With Endoscopic Response at 16 Weeks Followed by Clinical and Endoscopic Remission at 52 Weeks in Subjects With Active Moderate Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective is to determine the efficacy of rifaximin DR also referred to as Extended Intestinal Release (EIR) tablets vs. placebo for the induction of clinical remission and endoscopic response following 16 weeks of treatment in participants presenting with active moderate Crohn's disease. A key secondary objective is to evaluate clinical and endoscopic remission following an additional 36 weeks of treatment.
Study identification
- NCT ID
- NCT02240108
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 81 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 28, 2014 (Actual)
- Primary completion
- Oct 6, 2017 (Actual)
- Completion
- Oct 6, 2017 (Actual)
- Last update posted
- Sep 10, 2019
2014 – 2017
United States locations
- U.S. sites
- 78
- U.S. states
- 29
- U.S. cities
- 71
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | 35802 | — |
| Not listed | Tucson | Arizona | 85710 | — |
| Not listed | Tucson | Arizona | 85712 | — |
| Not listed | Tucson | Arizona | 85741 | — |
| Not listed | Sherwood | Arkansas | 72120 | — |
| Not listed | Garden Grove | California | 92845 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | La Mirada | California | 90638 | — |
| Not listed | Laguna Hills | California | 92653 | — |
| Not listed | Los Angeles | California | 90045 | — |
| Not listed | Northridge | California | 91324 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | Littleton | Colorado | 80120 | — |
| Not listed | Waterbury | Connecticut | 06708 | — |
| Not listed | Boca Raton | Florida | 33428 | — |
| Not listed | Clearwater | Florida | 33756 | — |
| Not listed | Coral Gables | Florida | 33173 | — |
| Not listed | Hollywood | Florida | 33021 | — |
| Not listed | Inverness | Florida | 34452 | — |
| Not listed | Lauderdale Lakes | Florida | 33319 | — |
| Not listed | Maitland | Florida | 32751 | — |
| Not listed | Miami | Florida | 33136 | — |
| Not listed | Miami | Florida | 33144 | — |
| Not listed | Miami | Florida | 33173 | — |
| Not listed | Miami Springs | Florida | 33166 | — |
| Not listed | Orange Park | Florida | 32073 | — |
| Not listed | Orlando | Florida | 32803 | — |
| Not listed | Palm Harbor | Florida | 33781 | — |
| Not listed | Port Orange | Florida | 32127 | — |
| Not listed | Tampa | Florida | 33603 | — |
| Not listed | Athens | Georgia | 30606 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Atlanta | Georgia | 30338 | — |
| Not listed | Macon | Georgia | 31201 | — |
| Not listed | Chicago | Illinois | 60624 | — |
| Not listed | Evanston | Illinois | 60201 | — |
| Not listed | Iowa City | Iowa | 52242 | — |
| Not listed | Crestview Hills | Kentucky | 41017 | — |
| Not listed | Shreveport | Louisiana | 71102 | — |
| Not listed | West Monroe | Louisiana | 71291 | — |
| Not listed | Hagerstown | Maryland | 21742 | — |
| Not listed | Hollywood | Maryland | 20636 | — |
| Not listed | Brockton | Massachusetts | 02302 | — |
| Not listed | Caro | Michigan | 48723 | — |
| Not listed | Stevensville | Michigan | 49127 | — |
| Not listed | Wyoming | Michigan | 49519 | — |
| Not listed | Plymouth | Minnesota | 55446 | — |
| Not listed | Ocean Springs | Mississippi | 39564 | — |
| Not listed | Tupelo | Mississippi | 60624 | — |
| Not listed | Bridgeton | Missouri | 63044 | — |
| Not listed | Creve Coeur | Missouri | 63141 | — |
| Not listed | Vineland | New Jersey | 08360 | — |
| Not listed | Voorhees Township | New Jersey | 08043 | — |
| Not listed | New York | New York | 10016 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Fayetteville | North Carolina | 28304 | — |
| Not listed | Kinston | North Carolina | 28501 | — |
| Not listed | Beavercreek | Ohio | 45440 | — |
| Not listed | Cincinnati | Ohio | 45219 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Kettering | Ohio | 45429 | — |
| Not listed | Lima | Ohio | 45806 | — |
| Not listed | Oklahoma City | Oklahoma | 73102 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | Fort Mill | South Carolina | 29707 | — |
| Not listed | Dallas | Texas | 75231 | — |
| Not listed | Houston | Texas | 77036 | — |
| Not listed | Houston | Texas | 77099 | — |
| Not listed | Humble | Texas | 77338 | — |
| Not listed | San Antonio | Texas | 78229 | — |
| Not listed | Tyler | Texas | 75701 | — |
| Not listed | Ogden | Utah | 84405 | — |
| Not listed | West Jordan | Utah | 84088 | — |
| Not listed | West Valley City | Utah | 84120 | — |
| Not listed | Chesapeake | Virginia | 23320 | — |
| Not listed | Richland | Washington | 99352 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02240108, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 10, 2019 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02240108 live on ClinicalTrials.gov.